Odin Pharmaceuticals
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
300 Franklin Square Dr, Somerset, New Je...Phone Number
(732) 554-1100Website
www.odinpharmaceuticals.comRevenue
<$5 MillionIndustry
About Odin Pharmaceuticals
Odin Pharmaceuticals is a sterile pharmaceutical company that develops and markets injectable and ophthalmic drugs for the US healthcare market. Founded in 2018 by Dr. Veerappan Subramanian and Dr. Ilango Subramanian, the company boasts a robust pipeline of products. Their focus is primarily on providing high-quality generics and innovative solutions in sterile drug delivery. Odin Pharmaceuticals aims to serve healthcare providers and patients seeking reliable pharmaceutical options.Explore more
Odin Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Odin Pharmaceuticals
Compare insights from companies similar to Odin Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Odin Pharmaceuticals Tech Stack
A closer look at the technologies used by Odin Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Odin Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Odin Pharmaceuticals is a sterile pharmaceutical company that develops and markets injectable and ophthalmic drugs for the US healthcare market. Founded in 2018 by Dr. Veerappan Subramanian and Dr. Ilango Subramanian, the company boasts a robust pipeline of products. Their focus is primarily on providing high-quality generics and innovative solutio... Read More
